Lifetime Cost-Utility Analysis of Patients with Refractory Epilepsy Treated with Adjunctive Topiramate Therapy: Cost-Effectiveness in Refractory Epilepsy

By Maltoni S.   Messori A.  

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 225-232

Adis International

Access to resources Recommend Favorite

Topiramate as an Adjunctive Treatment for Refractory Partial Epilepsy in the Elderly

By Zhang L   Huang J   Zhuang J-H   Huang L-Q   Zhao Z-X  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 408-415

Field House Publishing

Access to resources Recommend Favorite

Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory Epilepsy: A Prospective, Open-Label, Observational, Multicenter Study in Spain

By Casas-Fernández Carlos  

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 187-197

Adis International

Access to resources Recommend Favorite

Lacosamide in patients with pharmacoresistant epilepsy

By Verrotti Alberto   Loiacono Giulia   Olivieri Cristina   Zulli Enrico   Zaccara Gaetano  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2065-2072

Informa Healthcare

Access to resources Recommend Favorite

Topiramate as an Adjunctive Treatment in Patients with Refractory Status Epilepticus: An Observational Cohort Study

By Hottinger Annalena  

CNS Drugs, Vol. 26, Iss. 9, 2012-09 ,pp. : 761-772

Adis International

Access to resources Recommend Favorite